Kewaunee Scientific Corp (KEQU) stock
Close on Nov 13, 2026Market cap $103.36MP/E 12.9Yield –
Kewaunee Scientific Corp grew revenue 5.3% to $277.22M over the twelve months to Jul 31, 2026. Operating income fell 24.7% to $15.06M, moving the operating margin from 7.6% to 5.4%. Free cash flow was $10.88M, down 41.8% from a year earlier. At the latest close the market valued the company at $103.36M, 12.9 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jul 31, 2026
Valuation
- Market cap
- $103.36M
- P/E ratio
- 12.9
- Price to sales
- 0.37
- Price to book
- 1.38
- Dividend yield
- –
- Free cash flow yield
- 10.53%
Fundamentals
- Revenue
- $277.22M
- Net income
- $8.23M
- EPS, diluted
- $2.76
- Free cash flow
- $10.88M
- Book value per share
- $25.68
- Diluted shares
- 3M
Trading
- Next earnings
- Dec 9, 2026 (estimated, during market hours)
- Previous close
- $35.94
- Open
- $35.90
- Day's range
- $35.48 – $35.90
- Volume
- 1,722
- Average volume (20 days)
- 4,507
- Beta (5 years)
- 0.35
- 52-week range
- $32.00 – $43.36
- RSI (14 days)
- 62.4
- Volatility (1 year)
- 35.1%
- Relative volume
- 0.40×
- WACC
- 8.1%
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | KEQU | S&P 500 | Difference | KEQU per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +10.9% | -3.0% | +13.9 pts | ||
| 3 months | -2.3% | -2.8% | +0.5 pts | ||
| Year to date | -4.6% | +11.5% | −16.1 pts | ||
| 1 year | -10.9% | +13.5% | −24.3 pts | ||
| 3 years | +98.2% | +77.7% | +20.5 pts | +25.6% | +21.1% |
| 5 years | +175.8% | +72.6% | +103.2 pts | +22.5% | +11.5% |
| 10 years | +76.7% | +308.2% | −231.5 pts | +5.9% | +15.1% |
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Kewaunee Scientific filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Results
- Update
- Update
- News
About Kewaunee Scientific
Laboratory Apparatus & Furniture
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. Its product offerings include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, biological safety cabinets, and epoxy resin work surfaces and sinks. Following its acquisition of Nu Aire, Inc., the company also supplies airflow products, carbon dioxide incubators, ultralow freezers, animal handling equipment, and pharmacy compounding isolators. Additionally, its international operations offer laboratory facility design, engineering construction, and project management services. Kewaunee serves customers across pharmaceutical, biotechnology, industrial, education, healthcare, and government sectors. It operates through two primary segments: Lab Products Group and International.
Company profile, executives and historyKewaunee Scientific stock: common questions
What is Kewaunee Scientific's stock price?
KEQU closed at $35.70 on Nov 13, 2026, down 0.67% on the day. Over the past 52 weeks it traded between $32.00 and $43.36.
What is Kewaunee Scientific's market cap?
Kewaunee Scientific was worth $103.36M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is KEQU's P/E ratio?
KEQU trades at 12.9 times earnings, based on diluted earnings per share of $2.76 over the twelve months to Jul 31, 2026.
How much revenue does Kewaunee Scientific make?
Kewaunee Scientific reported revenue of $277.22M for the twelve months to Jul 31, 2026, up 5.3% from a year earlier.
Does Kewaunee Scientific pay a dividend?
No. Kewaunee Scientific has not paid a cash dividend over the last twelve months.
When does Kewaunee Scientific report earnings next?
Kewaunee Scientific is expected to report Q2 FY2027 results on Dec 9, 2026, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has KEQU stock performed over the past year?
Including dividends, KEQU returned -10.9% over the past year, against +13.5% for the S&P 500.
How many KEQU shares are sold short?
0M shares were sold short at the latest FINRA report, 1.58% of the float, or 14.4 days of average trading volume.
Who are Kewaunee Scientific's competitors?
Companies most similar to Kewaunee Scientific by business, industry and size include MLAB, INTT, CTKB, HURC, SYPR.
See a number that looks wrong?